Fludeoxyglucose Completed Phase 2 Trials for Multiple Myeloma (MM) Diagnostic

IndicationsStatusPurposePhase
CompletedDiagnostic2
clinicaltrials.gov IdentifierTitleDrugs
NCT03262389Comparison of F-18 FDG and C-11 Acetate PET in Multiple Myeloma